Print this page Print this page      Email this page Email this page     Text Size: A  A  A     Click Here to Sign In
Home > MS Treatment > MS Treatment Options > NOVANTRONE® (mitoxantrone for injection concentrate)

NOVANTRONE®

(mitoxantrone for injection concentrate)

NOVANTRONE is used to reduce relapses and disability in patients with the following forms of MS:

  • secondary (chronic) progressive
  • progressive relapsing
  • worsening relapsing-remitting

NOVANTRONE is not for patients with primary progressive MS.

View Clinical Benefits

Dosing regimen:

  • NOVANTRONE is administered by infusion at an infusion center or a specially equipped doctor's office. It is given once every 3 months.
Clinical Benefits

NOVANTRONE® (mitoxantrone for injection concentrate) Clinical Benefits

  • Slows the progression of disability
  • Lengthens the time between relapses
Personalize Your Own MS ActiveSource Homepage
Register now to start using these helpful online tools.
  • My MS Memory Builder
  • My MS Calendar
  • My MS Logbook
Already have a profile? Sign In
Managing Treatment Side Effects All MS treatments have side effects. Get tips on how to manage them. Learn more
Staying on Treatment Find information on the importance of staying on treatment for MS. Learn more


Call an MS Support Specialist: 1.800.456.2255

Elan  |  Contact Us  |  Privacy Policy  |   Legal Disclaimer  |  Site Map

© 2009 Biogen Idec. All rights reserved. MSActiveSource is a registered trademark of Biogen Idec. MSActiveSource is sponsored by Biogen Idec and Elan Pharmaceuticals.

BIOGEN IDEC and the BIOGEN IDEC logo are registered trademarks of BIOGEN IDEC.
The Elan logo is a registered trademark of Elan Corporation, PLC.